Skip to Main Content
This presentation will focus on the regulatory process followed when commercializing technology designed to predict/detect seizures. The author will describe the general requirements required to commercialize implantable medical products in the various regions of world. He will contrast the differences in the requirements for different regions and describe efforts to harmonize those requirements between the European Community and the United States. Furthermore he will identify some of the unique clinical and regulatory issues associated with commercializing a seizure management system incorporating algorithms for processing biosignals to predict/detect seizures.